Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using a Specialized MRI Technique Called Multiexponential T2 Component Analysis
18 Years
N/A
Both
Glioma
Trial Information
Investigation Into the Differentiation of Tumour and Healthy Brain Tissue Using a Specialized MRI Technique Called Multiexponential T2 Component Analysis
Existing methods of contouring tumours for radiation therapy involve manual interpretations
of qualitative diagnostic images. These methods, being qualitative, do not offer a
consistent and reproducible platform for contouring, making it difficult to evaluate the
effects of contouring choices on treatment outcome. T2 component analysis in MRI has the
potential to offer a quantitive basis for identifying tumor tissue- this potential is
investigated in this pilot study.
Inclusion Criteria:
- Eighteen years of age or older
- Clinical subjects must have not yet begun radiation therapy
- Must have signed our study-specific consent form
Exclusion Criteria:
-
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
T2 characteristics of glioma tissue versus normal
Outcome Time Frame:
Before radiotherapy treatment begins
Safety Issue:
No
Principal Investigator
Keith Wachowicz, PhD
Investigator Role:
Study Chair
Investigator Affiliation:
Alberta Health Services
Authority:
Canada: Health Canada
Study ID:
CNS-24534
NCT ID:
NCT00813787
Start Date:
February 2009
Completion Date:
May 2012
Related Keywords:
- Glioma
- Magnetic Resonance Imaging
- Glioma
- Glioma
Name | Location |
|---|
